THIS MESSAGE (MATERIAL) IS CREATED AND (OR) DISTRIBUTED BY A FOREIGN MASS MEDIA PERFORMING THE FUNCTIONS OF A FOREIGN AGENT AND (OR) A RUSSIAN LEGAL ENTITY PERFORMING THE FUNCTIONS OF A FOREIGN AGENT.
Buying medicines out of fear that there will be a shortage is pointless, since stocks are plentiful in warehouses, and many medicines have a limited shelf life. Nikolai Izmalkov, scientific consultant of the NTI Center for Bionic Engineering in Medicine, Samara State Medical University, chief physician of the university clinics, told about this in an interview with RIA Novosti.
According to him, “such actions only cause unhealthy excitement and artificial scarcity.” “In fact, there are no problems with drugs. The fact is that large federal pharmacy chains have fairly large warehouses that can provide retail drugs for several months. Plus, pharmacy chains can close deliveries to medical institutions under existing contracts, ”the expert noted.
In addition, he pointed out, it is irrational and unreasonable to stock up on medicines, since they have a limited expiration date.
“There are no significant force majeure events for medicines. Medicines and medical products are not subject to sanctions. So far, the most difficult issue is the logistics and ways of delivering medicines. All major suppliers will address this issue. During the time that the warehouses are empty, new supply chains will be formed, and the supply of drugs will resume. Yes, the price may change, but it will depend on the exchange rate, and not on logistics, ”concluded Izmalkov.
Back in early March, the head of the Ministry of Health of the Russian Federation, Mikhail Murashko, assured that the situation with drugs was stable, and significant stocks of drugs had been formed. According to him, foreign producers continue to work with Russia, no statements have been made regarding restrictions on supplies from abroad.
We also recall that earlier this week it became known that the city authorities have developed a number of measures to support import substitution in the pharmaceutical industry in the face of sanctions. So, following the meeting of Moscow Mayor Sergei Sobyanin with representatives of large pharmaceutical companies, it became known that they would be provided with land plots for the construction of new production facilities at a rate of 1 ruble per year. In addition, the capital can simplify the procedure for registration and circulation of new domestic drugs and medical devices.
Source: Rosbalt
Tristin is an accomplished author and journalist, known for his in-depth and engaging writing on sports. He currently works as a writer at 247 News Agency, where he has established himself as a respected voice in the sports industry.
